Viking Therapeutics Stock Price Chart


Viking Therapeutics

Last Price:
Seasonality Move:

7 Day Trial


$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

Viking Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 53.04 Sell
20-day SMA: 58.08 Sell
50-day SMA: 66.28 Sell
200-day SMA: 37.94 Buy
8-day EMA: 53.23 Sell
20-day EMA: 57.87 Sell
50-day EMA: 62.21 Sell
200-day EMA: 45.34 Buy

Viking Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.73 Sell
Relative Strength Index (14 RSI): 29.5 Sell
Chaikin Money Flow: -2265259 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.67 - 67.57) Sell
Bollinger Bands (100): (42.62 - 80.14) Sell

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Viking Therapeutics Stock

Is Viking Therapeutics Stock a Buy?

VKTX Technical Analysis vs Fundamental Analysis

Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy or a Sell?

Viking Therapeutics Stock Info

Market Cap:
Price in USD:
Share Volume:

Viking Therapeutics 52-Week Range

52-Week High:
52-Week Low:
Viking Therapeutics (VKTX) is a Sell

Viking Therapeutics Share Price Forecast

Is Viking Therapeutics Stock a Buy?

  • Viking Therapeutics share price is 50.64 while VKTX 8-day exponential moving average is 53.23, which is a Sell signal.
  • The stock price of VKTX is 50.64 while Viking Therapeutics 20-day EMA is 57.87, which makes it a Sell.
  • Viking Therapeutics 50-day exponential moving average is 62.21 while VKTX share price is 50.64, making it a Sell technically.
  • VKTX stock price is 50.64 and Viking Therapeutics 200-day simple moving average is 45.34, creating a Buy signal.

Fundamental Analysis of Viking Therapeutics

Is Viking Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.44 per share.

Technical Analysis of Viking Therapeutics

Should I short Viking Therapeutics stock?

* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.